Back

Impella RP versus pharmacologic vasoactive treatment in profound cardiogenic shock due to right ventricular failure: Unloading and end-organ perfusion in a large animal model

13 March 2021 (17:40 - 18:20)
Organised by:
Congress Presentation Part of: ACVC Research Prize Cardiogenic Shock ACVC Premium Access ACVC 2021

About the speaker

Photo
Doctor Jakob Josiassen

Novo Nordisk Foundation, Copenhagen (Denmark)

3 More presentations in this session

Presentation thumbnail
The interplay between myocardial bridging and coronary spasm in patients with myocardial infarction and non-obstructive coronary arteries: pathogenic and prognostic implications
Doctor R. Montone (Rome, IT)
Abstract Video
Presentation thumbnail
Impact of ESC-endorsed high ischemic risk features and ARC-high bleeding risk criteria on clinical outcomes in all-comer patients undergoing PCI
Doctor H. Wang (Beijing, CN)
Abstract Video
Presentation thumbnail
Preclinical testing of a novel pericardial left ventricular assist device (PALVAD)
Doctor A. Premawardhana (Leicester, GB)
Abstract Video

Access the full session

Session thumbnail
ACVC Research Prize
Video

The Event

Event poster

ACVC 2021

13 March 2021 17:40 CET
You may be interested in
thumbnail
Congress Presentation
The Impella percutaneous mechanical circulatory support device in cardiogenic shock: a single-center, real-world, observational experience.
1 September 2019
thumbnail
Congress Presentation
Intravenous vagal nerve stimulation catheter minimizes left ventricular pressure-volume loop and myocardial oxygen consumption in a dog supported with percutaneous left ventricular assist device
1 September 2025
thumbnail
Congress Presentation
Intermittent outpatient administration of levosimendan improves right ventricular-pulmonary arterial coupling in ambulatory patients with advanced heart failure
11 December 2020
thumbnail
Congress Session
Controversies in management of cardiogenic shock
25 March 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources